top of page

TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG

Product details

Registration number: SIN16161P

Classification: Prescription Only

Active ingredients: Tacrolimus monohydrate eqv tacrolimus

Strength: 1.0 mg

Dosage form: CAPSULE, EXTENDED RELEASE

Route: ORAL

Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

ATC code: L04AD02

HSA approval date: 21 April 2021

Manufacturer(s): Teva Pharmaceutical Works Private Limited Company

Manufacturing country/countries: HUNGARY

What are the HSA registration number and classification for TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16161P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Tacrolimus monohydrate eqv tacrolimus

Strength: 1.0 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: CAPSULE, EXTENDED RELEASE

Route: ORAL

Source for this answer

Who is the recorded registrant for TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG?

According to the HSA dataset updated 7 August 2026:

Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Teva Pharmaceutical Works Private Limited Company

Manufacturing country/countries: HUNGARY

Source for this answer

Where can I look up TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16161P or the exact product name TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this TACROLIMUS–TEVA PROLONGED RELEASE HARD CAPSULE 1MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16161P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page